Navigation Links
From eResearchTechnology to ERT

The Philadelphia-based company unveils its dynamic new identity and commits to 'Getting It Done, Right'

PHILADELPHIA, Feb. 26 /PRNewswire/ -- ERT (Nasdaq: ERES), the leading provider of best-in-class technology and services for the successful execution of clinical trials, today announced that, following extensive external and internal assessment, it is launching its new branding. Formerly eResearchTechnology, Inc., the company has adopted an entirely new image and character for the company following staff feedback and customer affirmation of its core values. The unrivalled business found that both customers and employees expect and receive a commitment from ERT that it will get the job done, and right. ERT is a dynamic and proactive organization that is committed to redefining and setting new standards of how clinical trials are successfully conducted.

This new brand strategy brings an enhanced visual identity to market as well as sharpened product positioning, a new web site, messaging and corporate collateral. As part of its new branding commitment ERT has introduced a new platform of products and services in the clinical trials arena to its customers worldwide. This consists of four sub-brands for ERT's industry-leading products and services: Cardiac Safety Solutions; EDC Solutions; ePRO Solutions and ERT Clinical Research Consulting Group. Cardiac Safety, EDC and ePRO Solutions are founded upon the company's innovative technology platform -- EXPERT(TM). EXPERT(TM) is a robust, secure and validated clinical-research workflow-processing system that powers centralized electronic data collection, data management and information exchange. All of ERT's solutions are supported by cross-functional teams operating within its SOP-driven, Project Assurance methodology that delivers exceptional performance metrics and customer satisfaction.

Originally founded in 1972 as Cardio Data Systems, the company moved its headquarters to Philadelphia in 1993 and following a series of acquisitions formed the company eResearchTechnology Inc. in 2000. "eResearchTechnology was known as a company that offered unparalleled service and comprehensive and reliable solutions which helped companies bring safe products to market," commented Michael McKelvey, President and CEO of ERT. "Our new brand identity reflects ERT's dynamism and passion while continuing to instill the confidence and trust that the industry has in our products and services. We see the change as a move forward in establishing the company as the most experienced and reliable partner in products and services for clinical trials. ERT gets the job done right."

For further information on ERT and its technology and services please email, call +1 215 972 0420 or visit

About ERT

Based in Philadelphia, PA, ERT (eResearchTechnology, Inc.) ( is a provider of technology and services to the biopharmaceutical and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis and distribution of clinical data in all phases of clinical development.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements, including, but not limited to 2008 financial guidance, involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

SOURCE eResearchTechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Post Your Comments:
(Date:11/26/2015)... SAN FRANCISCO , November 26, 2015 ... 1.82 billion by 2022, according to a new report by ... as Chronic Kidney Disease (CKD) which demands kidney transplantation is ... convenient and cost effective substitute for organ transplantation. --> ... 1.82 billion by 2022, according to a new report by ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/26/2015)... -- Research and Markets ( ) has announced ... by Type (Dressings, Therapy Devices, Active Wound Care), Application ... and Geography - Global Forecast to 2020" report ... --> The purpose of this report is ... global advanced wound care market. It involves deep dive ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... November 29, 2015 , ... Effective immediately, every single IguanaMed scrub style ... Black Friday Target is offering a “Buy One Scrub Set, Get the 2nd Scrub ... to purchase IguanaMed at a discounted price. , IguanaMed’s mission is to ...
(Date:11/28/2015)... ... ... Safe storage for contraceptive devices may not always be easy to find. ... the other from Bradley Beach, New Jersey, there is an easy solution to the ... replace NuvaRings more often than necessary. As such, it affords peace of mind and ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse ... the findings on the website. Click here to read the details now. ... who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who ...
Breaking Medicine News(10 mins):